Healthcare

What are the promises and limitations of different therapeutic modalities in solid tumors? As we approach the mid-year point, we reflect on the advancements in oncology in recent years.

Our evolutionary tale began 6 million years ago, when humans were programmed to hoard calories in a world of scarcity. Today, that ancient wiring has become our greatest health risk.

Mental health around the world continues to deteriorate according to the fifth edition of the AXA Mental Health Report. The study, conducted in collaboration with Ipsos, aims to identify mental health and well-being issues around the world in order to develop solutions to alleviate them. Ipsos surveyed 17,000 people from 16 countries across Europe, the United States and Asia.

Mental Health, AI, Infrastructure … Ipsos Update explores the latest and research & thinking on key topics from Ipsos teams around the world.

One of this century’s biggest game-changers will likely be a novel drug class that’s showing unprecedented success, or the promise of it, in treating some of the world’s most prevalent conditions.

Trends, News, Ageing … Ipsos Update explores the latest and research & thinking on key topics from Ipsos teams around the world.

The advent of groundbreaking therapies in the metabolic sector, including GLP-1, offers substantial opportunities for pharmaceutical companies, yet accurately estimating the size of these emerging markets, marked by significant unmet clinical needs, presents distinct challenges.

Across 31 countries 44% rate the quality of the healthcare they receive as good, but access to treatment and not enough staff are seen as major systemic challenges

Data, Healthcare, Education … Ipsos Update explores the latest and research & thinking on key topics from Ipsos teams around the world.